ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

St. Jude Director Cites Poor Housing’s Toll on Children, March 28, 1971

May 19, 2021

Upton Briefed On Problems; To Start July 25

July 15, 1977

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

Margaret Kripke Comes Out of Retirement To Become Chief Scientific Officer at CPRIT

December 14, 2012

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

February 26, 2010